Nephros Q4 2023 GAAP EPS $(0.060) Misses $(0.030) Estimate, Sales $3.300M Miss $3.813M Estimate
Nephros Q4 2023 GAAP EPS $(0.060) Misses $(0.030) Estimate, Sales $3.300M Miss $3.813M Estimate
Nephros 2023 年第四季度公認會計准則每股收益 (0.060 美元) 未達預期 (0.030)，銷售額 330 萬美元未達預期 381.3 萬美元
Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.060) per share which missed the analyst consensus estimate of $(0.030) by 100 percent. The company reported quarterly sales of $3.300 million which missed the analyst consensus estimate of $3.813 million by 13.47 percent. This is a 29.01 percent increase over sales of $2.558 million the same period last year.
Nephros（納斯達克股票代碼：NEPH）公佈的季度虧損爲每股0.060美元，比分析師普遍預期的美元（0.030美元）低100％。該公司公佈的季度銷售額爲33億美元，比分析師共識估計的381.3萬美元低13.47％。這比去年同期的255.8萬美元銷售額增長了29.01％。